Sign in
CompletedNo phase

Cochlear Implant With Dexamethasone Eluting Electrode Array

Key facts

Who runs it
Cochlear
Where
Englewood, Iowa City, and New York, United StatesSee the 4 sitesAlso in 2 other countries, 4 sites
Trial code
Status
Completed
People taking part
42 people enrolled
Started
4 Oct 2021
Ended
23 Feb 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • CI632D
  • CI632
Record updated
22 April 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Post-lingual, bilateral, moderate (≥ 40 dB HL) to profound sensorineural hearing loss at 250, 500and 1000 Hz and profound high-frequency hearing loss, defined by a pure-tone average (PTA) threshold, 2000 through 8000 Hz, ≥ 90 dB HL
  • 18 years or older at time of consent

Who cannot take part

  • History with cochlear implant surgery
  • Allergy to dexamethasone
  • Abnormal cochlear and middle ear anatomy
  • Women who are pregnant or plan to become pregnant
  • Unable/unwilling to comply to study requirements

Where in United States

Also in 2 other countries, 4 sites

  • Rocky Mountain Ear CentreEnglewood, United States
  • University of IowaIowa City, United States
  • New York Eye & Ear infirmary of Mt. SinaiNew York, United States
  • NYU Langone Medical CenterNew York, United States

About the trial

What the trial wants to find out

An evaluation of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.

The 2 groups in the trial

  • CI632D Investigational Medical Device (IMD)Treatment being tested

    Treatment: CI632D

  • CI632 Comparator DeviceExisting treatment, for comparison

    Treatment: CI632

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Cochlear Implant With Dexamethasone Eluting Electrode Array (The CI-DEX Study): Pivotal Study
Record updated
22 April 2025